Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:DFFN

Diffusion Pharmaceuticals (DFFN) Stock Price, News & Analysis

Diffusion Pharmaceuticals logo

About Diffusion Pharmaceuticals Stock (NASDAQ:DFFN)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$4.38
$6.60
52-Week Range
N/A
Volume
351,000 shs
Average Volume
10,937 shs
Market Capitalization
$8.98 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive DFFN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Diffusion Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

DFFN Stock News Headlines

Diffusion Pharmaceuticals Inc.
GENIUS Act: Cancel Your Money?
A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. Backed by the government but powered by private corporations, this initiative paves the way for digital dollars—programmable, trackable, and outside your control. Once embedded into apps, banks, and retail systems, opting out may no longer be possible. But there’s still time to protect your financial freedom—if you act before the system goes fully live.
See More Headlines

DFFN Stock Analysis - Frequently Asked Questions

Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN) released its quarterly earnings results on Wednesday, November, 10th. The company reported ($9.00) earnings per share for the quarter, missing analysts' consensus estimates of ($3.00) by $6.00.

Shares of Diffusion Pharmaceuticals reverse split before market open on Thursday, August 17th 2023.The 1-1.5 reverse split was announced on Thursday, August 17th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, August 17th 2023. An investor that had 100 shares of stock prior to the reverse split would have 67 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that Diffusion Pharmaceuticals investors own include Tonix Pharmaceuticals (TNXP), Onconova Therapeutics (ONTX), OPKO Health (OPK), T2 Biosystems (TTOO), NightHawk Biosciences (NHWK), Sorrento Therapeutics (SRNE) and TherapeuticsMD (TXMD).

Company Calendar

Last Earnings
11/10/2021
Today
8/07/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:DFFN
CIK
1053691
Employees
13
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$15.59 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-69.96%
Return on Assets
-62.98%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
10.71
Quick Ratio
10.71

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$6.97 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
2,040,000
Free Float
2,003,000
Market Cap
$8.98 million
Optionable
Not Optionable
Beta
1.78

Social Links

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (NASDAQ:DFFN) was last updated on 8/8/2025 by MarketBeat.com Staff
From Our Partners